CN1095674C - Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease - Google Patents

Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease Download PDF

Info

Publication number
CN1095674C
CN1095674C CN99115807A CN99115807A CN1095674C CN 1095674 C CN1095674 C CN 1095674C CN 99115807 A CN99115807 A CN 99115807A CN 99115807 A CN99115807 A CN 99115807A CN 1095674 C CN1095674 C CN 1095674C
Authority
CN
China
Prior art keywords
radix
herba
rhizoma
caulis
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99115807A
Other languages
Chinese (zh)
Other versions
CN1278446A (en
Inventor
贺云青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99115807A priority Critical patent/CN1095674C/en
Publication of CN1278446A publication Critical patent/CN1278446A/en
Application granted granted Critical
Publication of CN1095674C publication Critical patent/CN1095674C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a Chinese herbal medicine composition for treating cerebrovascular diseases, rheumatism and rheumatoid diseases. The present invention is prepared from fifty kinds of natural Chinese herbal medicine such as gastrodia tuber, uncaria stem, raw abalone shell, earthworm, etc. The present invention has the functions of activating blood circulation to dissipate blood stasis, stopping bleeding, dispelling wind, eliminating dampness, tonifying the liver and the kidney and strengthening the bone and the muscle. By the clinical application, the present invention has the advantages of over 98% of high treating rate, no toxic side effect, short treatment course, obvious treating effect, low expense and no relapse after medicine stoppage and can thoroughly treat cerebrovascular diseases, rheumatism and rheumatoid diseases.

Description

A kind of herbal composite for the treatment of cerebrovascular and rheumatic and rheumatoid diseases
The present invention relates to a kind of herbal composite (Dragon Lord looses) for the treatment of cerebrovascular and rheumatic and rheumatoid diseases.
The rheumatismal new drug of commercially available mainly treating rheumatism is a lot of, but major part contains hormone, but the period in a medicine pain relieving begins pain again after the drug withdrawal, and dosage time by time greatly can pain relieving, informal dress even can be addicted.The medicine that cures mainly cerebrovascular is also a lot, generally all will reach six months the course of treatment just can take effect, and cure rate is very low.
The object of the present invention is to provide a kind of herbal composite (Dragon Lord looses) for the treatment of cerebrovascular and rheumatic and rheumatoid diseases, short treating period, curative effect is fast, and cures the difficult recurrence in back.
Theory of Chinese medical science is thought: after cerebrovascular such as apoplectic hemiplegia, hemiplegia are the body apoplexy, and the resistance of the brain network stasis of blood, obstruction of collateral caused by windphlegm, blood stasis due to qi deficiency, asthenia of essence and blood is due to the mistake of the two muscles and bones thanks to of Liver and kidney is supported.Rheumatoid is to hold wet infiltration human body in the wind under the arm, wet impaction expectorant, and obstruction of collateral caused by windphlegm makes due to the resistance of QI and blood numbness.The inventor thinks that apoplexy is identical with the rheumatoid cause of disease, but is subjected to the position difference of pathogenic factor infringement, and it mainly is brain that apoplexy is subjected to the position of pathogenic factor infringement, and it mainly is limbs joint that rheumatoid is subjected to the position of pathogenic factor infringement, is reflected in just to have occurred different symptoms clinically.Therefore the inventor is according to the etiology and pathogenesis of two kinds of diseases, clinical symptoms, and in addition dialectical Analyses thinks that Therapeutic Method should be identical, according to blood circulation promoting competent silt, attacks expectorant to dispel the wind, relaxing muscles and tendons and activating QI and blood in the collateral, removing damp and stopping pain are main Therapeutic Principle.Why also do not have up to now to cure apoplexy, rheumatoid medicine, the inventor thinks that main cause is that medicine is not used, kind surplus the medicine of modern Chinese medicine voluminous dictionary record has 6000, be used for kind of a medicine surplus 400 clinical and have only in the prior art, up to now also find no the people and exceed routine and remove to open up, test, utilize some new medicines, cause that apoplexy, rheumatoid disease are not had new breakthrough on therapeutic effect.Caulis Erycibes among the side of the present invention, Herba Paederiae, Radix Parthenocissi Heterophyllae, geranium, Herba Sarcandrae, Herba Aristolochiae Mollissimae, Herba Aristolochiae, Caulis Trachelospermi, Caulis Sinomenii, valley dragon have all exceeded the scope of kind of medication surplus in the of conventional 400, thereby make apoplexy, rheumatoid curative effect that new breakthrough arranged.
The present invention is formed by 50 pleasant impression pure natural Chinese herbal medicine compatibilities.Rhizoma Gastrodiae in the side, Ramulus Uncariae Cum Uncis, Concha Haliotidis, Pheretima, Bombyx Batryticatus, Scorpio, Scolopendra, Herba speranskiae tuberculatae, the valley dragon, Radix Solani Melongenae, Zaocys, Folium Photiniae (Folium Photiniae serrulatae), Agkistrodon, process Radix Aconiti, Radix Aconiti Kusnezoffii Preparata, Radix Angelicae Pubescentis, Cortex Acanthopancis, Fructus Chaenomelis, Radix Gentianae Macrophyllae, Radix Clematidis, Faeces bombycis Herba Siegesbeckiae, Caulis Piperis Kadsurae, Ramulus Mori, Rhizoma Homalomenae, Herba Lycopodii, Rhizoma Atractylodis, Radix Stephaniae Tetrandrae, Rhizoma Panacis japonici, geranium, Caulis Sinomenii, Herba Aristolochiae Mollissimae, Herba Paederiae, Caulis Erycibes, Semen Strychni (processed), Radix Parthenocissi Heterophyllae, Herba Sarcandrae, Herba Aristolochiae, the Caulis Trachelospermi compatibility has very strong expelling wind and removing dampness, the removing obstruction in the collateral to relieve pain effect; Flos Carthami, Lignum Sappan, Radix Salviae Miltiorrhizae, Radix Achyranthis Bidentatae, Cortex Moutan, Rhizoma Chuanxiong, Myrrha, Olibanum, Squama Manis, Hirudo, Caulis Spatholobi compatibility are the optimal drug of blood nourishing acupuncture-stimulating, blood circulation promoting and blood stasis dispelling; The Cortex Eucommiae, Rhizoma Cibotii, Herba Epimedii, Radix Dipsaci, Rhizoma Curculiginis, Rhizoma Drynariae, Fructus Broussonetiae, Semen Astragali Complanati compatibility have the effect of very strong invigorating the liver and kidney, nourishing muscle and tendon bone; Sha Ruishi, Lignum Dalbergiae Odoriferae, Folium Callicarpae Formosanae, Radix Notoginseng, Radix Rubiae compatibility have the hemostasia and dissipation blood stasis effect of extra-heavy, and be excellent to the period of disease and the sequela curative effect of cerebral hemorrhage.
The present invention is made by the raw material of following weight ratio: Rhizoma Gastrodiae 15~50, Ramulus Uncariae Cum Uncis 15~50, Concha Haliotidis 15~50, Pheretima 15~50 Bombyx Batryticatus 15~50, Scorpio 10~40, Scolopendra 10~30, Herba speranskiae tuberculatae 15~50 valley dragons 15~50, Radix Solani Melongenae 15~50, Zaocys 15~50, Folium Photiniae (Folium Photiniae serrulatae) 15~50 Agkistrodons 10~50, process Radix Aconiti 5~25, Radix Aconiti Kusnezoffii Preparata 5~25, Radix Angelicae Pubescentis 15~50 Cortex Acanthopanciss 15~50, Fructus Chaenomelis 15~50, Radix Gentianae Macrophyllae 15~50, Radix Clematidis 15~50 Faeces bombyciss 15~50 Herba Siegesbeckiaes 15~50, Caulis Piperis Kadsurae 15~50, Ramulus Mori 15~50, Rhizoma Homalomenae 15~50, Herba Lycopodii 15~50, Rhizoma Atractylodis 15~50, Radix Stephaniae Tetrandrae 10~50, Rhizoma Panacis japonici 15~50, geranium 10~50, Caulis Sinomenii 10~50, Herba Aristolochiae Mollissimae 10~50, Herba Paederiae 10~50, Caulis Erycibes 10~50, Semen Strychni (processed) 0.5~5, Flos Carthami 5~50, Lignum Sappan 5~50, Radix Achyranthis Bidentatae 10~50, Radix Salviae Miltiorrhizae 10~50, Cortex Moutan 10~50, Rhizoma Chuanxiong 10~50, Myrrha 10~50, Olibanum 10~50, Squama Manis 10~50, Hirudo 10~40, Caulis Spatholobi 10~50, the Cortex Eucommiae 10~50, Rhizoma Curculiginis 10~50, Rhizoma Cibotii 10~50, Radix Dipsaci 10~50, Rhizoma Drynariae 10~5 0, Herba Epimedii 10~50, Fructus Broussonetiae 10~100, Semen Astragali Complanati 10~100, Radix Parthenocissi Heterophyllae 10~50, Herba Sarcandrae 10~50, Herba Aristolochiae 10~50, Caulis Trachelospermi 10~50.
The present invention forms with the principle compatibility of the theory of Chinese medical science mutual reinforcement between mutual-assistance, reaches blood circulation promoting and blood stasis dispelling jointly, hemostasis expelling wind and removing dampness, removing obstruction in the collateral to relieve pain, invigorating the liver and kidney, bone and muscle strengthening effect.Take a 1-2 of the present invention course of treatment through clinical observation, each rheumatoid disease, rheumatoid total effective rate are reached more than 90%, total effective rate to apoplectic hemiplegia also reaches more than 90%, have no side effect, short treating period, curative effect are fast, and expense is low, does not recur after the drug withdrawal, can thoroughly cure cerebrovascular and rheumatic and rheumatoid diseases.
Embodiment of the invention 1-3 (unit: g):
Embodiment 1 embodiment 2 embodiment 3
Rhizoma Gastrodiae 20 35 50
Bombyx Batryticatus 25 30 45
Valley dragon 20 35 45
Agkistrodon 15 25 35
Cortex Acanthopancis 20 35 50
Faeces bombycis 15 25 35
Rhizoma Homalomenae 20 40 50
Rhizoma Panacis japonici 15 25 45
Herba Paederiae 25 30 50
Lignum Sappan 15 25 45
Rhizoma Chuanxiong 20 35 50
Hirudo 10 15 35
Rhizoma Cibotii 20 35 50
Fructus Broussonetiae 25 40 50
Ramulus Uncariae Cum Uncis 15 25 35
Scorpio 15 20 35
Radix Solani Melongenae 17 26 35
Moxibustion Radix Aconiti 10 15 25
Fructus Chaenomelis 15 25 40
Herba Siegesbeckiae 25 35 50
Herba Lycopodii 15 25 40
Geranium 20 35 50
Caulis Erycibes 15 25 40
Radix Achyranthis Bidentatae 25 30 45
Myrrha 20 30 45
Caulis Spatholobi 35 45 50
Radix Dipsaci 15 20 35
Semen Astragali Complanati 20 30 45
Concha Haliotidis 20 35 50
Scolopendra 15 20 30
Zaocys 17 25 45
Radix Aconiti Kusnezoffii Preparata 10 15 25
Radix Gentianae Macrophyllae 15 25 50
Caulis Piperis Kadsurae 20 30 45
Rhizoma Atractylodis 25 35 50
Caulis Sinomenii 20 30 45
Semen Strychni (processed) 0.5 24
Radix Salviae Miltiorrhizae 15 25 50
Olibanum 17 20 45
The Cortex Eucommiae 20 35 50
Rhizoma Drynariae 15 25 35
Pheretima 15 25 45
Herba speranskiae tuberculatae 25 30 50
Folium Photiniae (Folium Photiniae serrulatae) 15 25 45
Radix Angelicae Pubescentis 20 35 50
Radix Clematidis 25 30 45
Ramulus Mori 20 35 40
Radix Stephaniae Tetrandrae 10 20 35
Herba Aristolochiae Mollissimae 15 25 40
Flos Carthami 17 30 50
Cortex Moutan 12 20 45
Squama Manis 15 25 30
Rhizoma Curculiginis 17 30 45
Herba Epimedii 15 25 50
Radix Parthenocissi Heterophyllae 15 20 35
Herba Sarcandrae 18 25 30
Herba Aristolochiae 17 30 45
Caulis Trachelospermi 15 40 50
Preparation method: every flavor prescription is solely pulverized to slightly not, pressed mixing behind the desired content compatibility, the plastic bag sealing of packing into after dosage 400~500g in order position packs with gauze then gets final product.In order to keep the pure natural drug effect, the moistening of preferably medicine being sprayed water before the pulverizing is to avoid the drug effect of volatilizing in the grinding and processing process.When taking unit dose medicated powder added in marmite that boiled water is an amount of to be soaked five minutes, exchange uniform for three times at a simmer, make about medicinal liquid 2500ml, clothes were three times on 1st, each 100ml, and taking medicine before meal usefulness, taking three months is a course of treatment, can cure general 1-2 course of treatment.

Claims (1)

1, a kind of herbal composite for the treatment of cerebrovascular and rheumatic and rheumatoid diseases is characterized in that described herbal composite made by the raw material of following weight ratio: Rhizoma Gastrodiae 15~50, Ramulus Uncariae Cum Uncis 15~50, Concha Haliotidis 15~50, Pheretima 15~50 Bombyx Batryticatus 15~50, Scorpio 10~40, Scolopendra 10~30, Herba speranskiae tuberculatae 15~50 valley dragons 15~50, Radix Solani Melongenae 15~50, Zaocys 15~50, Folium Photiniae (Folium Photiniae serrulatae) 15~50 Agkistrodons 10~50, process Radix Aconiti 5~25, Radix Aconiti Kusnezoffii Preparata 5~25, Radix Angelicae Pubescentis 15~50 Cortex Acanthopanciss 15~50, Fructus Chaenomelis 15~50, Radix Gentianae Macrophyllae 15~50, Radix Clematidis 15~50 Faeces bombyciss 15~50 Herba Siegesbeckiaes 15~50, Caulis Piperis Kadsurae 15~50, Ramulus Mori 15~50, Rhizoma Homalomenae 15~50, Herba Lycopodii 15~50, Rhizoma Atractylodis 15~50, Radix Stephaniae Tetrandrae 10~50, Rhizoma Panacis japonici 15~50, geranium 10~50, Caulis Sinomenii 10~50, Herba Aristolochiae Mollissimae 10~50, Herba Paederiae 10~50, Caulis Erycibes 10~50, Semen Strychni (processed) 0.5~5, Flos Carthami 5~50, Lignum Sappan 5~50, Radix Achyranthis Bidentatae 10~50, Radix Salviae Miltiorrhizae 10~50, Cortex Moutan 10~50, Rhizoma Chuanxiong 10~50, Myrrha 10~50, Olibanum 10~50, Squama Manis 10~50, Hirudo 10~40, Caulis Spatholobi 10~50, the Cortex Eucommiae 10~50, Rhizoma Curculiginis 10~50, Rhizoma Cibotii 10~50, Radix Dipsaci 10~50, Rhizoma Drynariae 10~50, Herba Epimedii 10~50, Fructus Broussonetiae 10~00, Semen Astragali Complanati 10~100, Radix Parthenocissi Heterophyllae 10~50, Herba Sarcandrae 10~50, Herba Aristolochiae 10~50, Caulis Trachelospermi 10~50.
CN99115807A 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease Expired - Fee Related CN1095674C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99115807A CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99115807A CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Publications (2)

Publication Number Publication Date
CN1278446A CN1278446A (en) 2001-01-03
CN1095674C true CN1095674C (en) 2002-12-11

Family

ID=5278719

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99115807A Expired - Fee Related CN1095674C (en) 1999-06-18 1999-06-18 Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease

Country Status (1)

Country Link
CN (1) CN1095674C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700360B (en) * 2009-09-12 2012-05-09 高兴亮 Chinese medicine prescription for curing bi syndrome

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100339085C (en) * 2003-09-23 2007-09-26 天津天士力制药股份有限公司 Combination of Chinese traditional medicine for curing cardiovascular and cerebrovascular diseases
CN100344315C (en) * 2005-06-03 2007-10-24 江苏康缘药业股份有限公司 Medicinal composition for promoting bone fracture healing and its preparing method
CN101708322B (en) * 2009-12-09 2012-02-22 邓仁清 Rheumatism-treating medicinal liquor
CN102225125B (en) * 2011-06-21 2013-06-05 马玉伟 Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof
CN102357173B (en) * 2011-10-21 2014-04-02 于明儒 Traditional Chinese medicine formula for curing rheumatism
CN102370731B (en) * 2011-10-27 2014-01-29 姜永兰 Medicament for treating prolapse of lumbar intervertebral disc, hyperosteogeny and hydrarthrosis and preparation method thereof
CN102805824B (en) * 2012-08-25 2013-10-30 兰恒志 Drug for curing apoplexy and preparation method thereof
CN102961558B (en) * 2012-12-11 2014-02-19 楚雄蕴萃生物科技有限公司 Patch and preparation method thereof
CN103655993B (en) * 2013-12-10 2015-10-21 刘萍 A kind of Chinese medicine for the treatment of apoplexy and preparation method thereof
CN103751545B (en) * 2014-01-12 2016-06-01 戴聪军 A kind of Chinese medicine preparation treating type of deficiency of both QI and YIN IgA nephropathy
CN103798735A (en) * 2014-03-07 2014-05-21 哈尔滨灵椿味道食品开发有限公司 Cassia twig hot-pot flavoring capable of warming channels and dredging collaterals and production method thereof
CN104288519A (en) * 2014-10-28 2015-01-21 李云鹏 Blood circulation-activating and pain-alleviating ointment
CN104587437A (en) * 2015-01-31 2015-05-06 陈西初 Plaster for treatment of stroke paralysis and preparation method thereof
CN105125732A (en) * 2015-09-11 2015-12-09 李传义 Traditional Chinese medicinal powder for rheumatism and preparation method of traditional Chinese medicinal powder
CN106723633A (en) * 2016-11-18 2017-05-31 安徽省天和鞋服有限责任公司 A kind of Health care cloth shoes with alleviation rheumatalgia pain function and preparation method thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1147950A (en) * 1996-04-30 1997-04-23 郭约翰 oral liquid for preventing and treating cerebrovascular disease
CN1163118A (en) * 1996-04-23 1997-10-29 张文胜 Chinese drug preparation for curing diseases of cardio-cerebral vascular system

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1163118A (en) * 1996-04-23 1997-10-29 张文胜 Chinese drug preparation for curing diseases of cardio-cerebral vascular system
CN1147950A (en) * 1996-04-30 1997-04-23 郭约翰 oral liquid for preventing and treating cerebrovascular disease

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101700360B (en) * 2009-09-12 2012-05-09 高兴亮 Chinese medicine prescription for curing bi syndrome

Also Published As

Publication number Publication date
CN1278446A (en) 2001-01-03

Similar Documents

Publication Publication Date Title
CN1095674C (en) Chinese medicinal composition for cerebrovascular disease, rheumatism and rheumatoid disease
CN1286474C (en) Medicine for treating bone wound
CN1947790A (en) Medicine for treating paralysis and its prepn. method
CN1966003A (en) Externally applied medicament for treating rheumatism
CN1180556A (en) Medicated wine for treating rheumatalgia
CN1285364C (en) Chinese medicinal composition for treating cervical vertebra disease, lumbar vertebra disease and ischialgia
CN1211103C (en) Oral taken and external use medicine for antirheumatism and stopping numbness pain
CN1149094C (en) Shehong Gugui medicated wine
CN1111046C (en) Chinese medicine preparation for curing postpartum disease of woman
CN1478525A (en) Medicated wine for treating traumatic injury
CN1049586C (en) Dressing medicine for treating hyperosteogeny and the prepn. method
CN101138625A (en) Chinese medicine composition for treating omarthritis
CN1308025C (en) Medicine for treating paraplegia and its preparing method
CN106511671A (en) Medicinal liquor for treating hyperostosis, rheumatism and gout disease
CN1663577A (en) Chinese medicinal composition for treating rheumatic and rheumatoid arthritis
CN1290551C (en) A Chinese medicinal composition for invigorating kidney and strengthening bone
CN1092971C (en) Chinese medicine for treating rheumatism
CN1101202C (en) Compound Chinese medicine preparation for treating hyperosteogeny
CN1186028C (en) Antagesic Chinese medicine and its preparing process and usage
CN1219402A (en) Chinese medicinal pill for curing rheumatism and rheumatoid disease and its preparation method
CN1481876A (en) Medication for virus hepatitis and hepatocirrhosis
CN1241602C (en) Oral administered medicated wine for treating cardiovascular and cerebrovascular diseases
CN1470261A (en) Medicated spirit for treating rheumatism
CN1127978C (en) Hyperosteogeny treating medicine
CN1698801A (en) Capsule for treating hemiplegia and rheumatism

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee